Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis
Background: Eosinophilic otitis media (EOM) is a refractory condition associated with eosinophilic chronic rhinosinusitis and bronchial asthma. EOM is characterized by type-2 inflammation and is refractory to various treatments. We investigated the efficacy of dupilumab, interleukin-4 receptor alpha...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2023-10-01
|
| Ráidu: | Allergology International |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S1323893023000382 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|